000 01577 a2200469 4500
005 20250517185320.0
264 0 _c20190207
008 201902s 0 0 eng d
022 _a1029-2403
024 7 _a10.1080/10428194.2017.1397664
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAw, Andrew
245 0 0 _aMinimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometry.
_h[electronic resource]
260 _bLeukemia & lymphoma
_c08 2018
300 _a1986-1989 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aFlow Cytometry
_xmethods
650 0 4 _aHumans
650 0 4 _aImmunoglobulins
_xgenetics
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aNeoplasm, Residual
_xdiagnosis
650 0 4 _aPrognosis
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
650 0 4 _aSequence Analysis, DNA
_xmethods
650 0 4 _aSurvival Analysis
700 1 _aKim, Haesook T
700 1 _aFernandes, Stacey M
700 1 _aHoang, Kevin
700 1 _aKasar, Siddha
700 1 _aFaham, Malek
700 1 _aBrown, Jennifer R
773 0 _tLeukemia & lymphoma
_gvol. 59
_gno. 8
_gp. 1986-1989
856 4 0 _uhttps://doi.org/10.1080/10428194.2017.1397664
_zAvailable from publisher's website
999 _c27814894
_d27814894